Mark Goldsmith – Biography
Last update: 12 days agoExecutive profile
Mark was Venture Partner at Third Rock Ventures, and Executive Chairman at Constellation Pharmaceuticals.
Mark Goldsmith is currentlyPresident, Chief Executive Officer and Board Chairman at Revolution Medicines - View - Revolution Medicines org chart
Director at Nura Bio - View - Nura Bio org chart
Create your alert
to follow the career of Mark Goldsmith.
Education
Mark Goldsmith has a Doctor of Philosophy in Microbiology and Immunology from University of California, San Francisco in 1988 and a Doctor of Medicine from University of California, San Francisco - School of Medicine in 1990.
They have also studied at University of California, San Francisco :
Find more alumni from University of California, San Francisco
They have also studied at University of California, San Francisco - School of Medicine :
- Pushkal Garg - Alnylam Pharmaceuticals
- Lauren Smith - Blue Cross Blue Shield of Massachusetts
- Ari Hoffman - Collective Health
Find more alumni from University of California, San Francisco - School of Medicine
More about Mark Goldsmith
Selected links
Do you need to know more about Mark Goldsmith? More results.
Participate
Social media
- Mark Goldsmith on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mark Goldsmith
The colleagues of Mark Goldsmith
Company Colleagues
- At Revolution Medicines, Mark Goldsmith has 41 colleagues including Lorence Kim (Director), Thilo Schroeder (Director)…
- At Nura Bio, Mark Goldsmith has 12 colleagues including Shilpa Sambashivan (CEO & Science), Sanjay Keswani (Director)…
Homonyms
- Mark Goldsmith - Chief Operating Officer - GMM Pfaudler
Industry Colleagues
- In the Pharmaceuticals industry, Mark Goldsmith has 22,990 colleagues in 1,913 companies located in 68 countries. 10,779 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Mark Goldsmith.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Mark Goldsmith.
